ATA318081A - Verfahren zur herstellung von topischen verfahren zur herstellung von topischen pharmazeutischen zubereitungen pharmazeutischen zubereitungen - Google Patents

Verfahren zur herstellung von topischen verfahren zur herstellung von topischen pharmazeutischen zubereitungen pharmazeutischen zubereitungen

Info

Publication number
ATA318081A
ATA318081A AT0318081A AT318081A ATA318081A AT A318081 A ATA318081 A AT A318081A AT 0318081 A AT0318081 A AT 0318081A AT 318081 A AT318081 A AT 318081A AT A318081 A ATA318081 A AT A318081A
Authority
AT
Austria
Prior art keywords
pharmaceutical preparations
producing topical
producing
methods
topical
Prior art date
Application number
AT0318081A
Other languages
English (en)
Other versions
AT381025B (de
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26276273&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATA318081(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of ATA318081A publication Critical patent/ATA318081A/de
Application granted granted Critical
Publication of AT381025B publication Critical patent/AT381025B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT0318081A 1980-07-18 1981-07-17 Verfahren zur herstellung von topischen pharmazeutischen zubereitungen AT381025B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8023645 1980-07-18
GB8033218A GB2080106B (en) 1980-07-18 1980-10-15 Acyclovin preparations

Publications (2)

Publication Number Publication Date
ATA318081A true ATA318081A (de) 1986-01-15
AT381025B AT381025B (de) 1986-08-11

Family

ID=26276273

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0318081A AT381025B (de) 1980-07-18 1981-07-17 Verfahren zur herstellung von topischen pharmazeutischen zubereitungen

Country Status (30)

Country Link
EP (1) EP0044543B1 (de)
AR (1) AR225680A1 (de)
AT (1) AT381025B (de)
AU (1) AU547391B2 (de)
BG (1) BG60450B2 (de)
CA (1) CA1172169A (de)
CS (1) CS229674B2 (de)
CY (1) CY1309A (de)
DD (1) DD203464A5 (de)
DE (1) DE3163982D1 (de)
DK (1) DK149191C (de)
ES (1) ES8305363A1 (de)
FI (1) FI76255C (de)
GB (1) GB2080106B (de)
GR (1) GR75104B (de)
HK (1) HK95485A (de)
HU (1) HU185936B (de)
IE (1) IE51120B1 (de)
IL (1) IL63351A (de)
IT (1) IT1171399B (de)
MC (1) MC1408A1 (de)
MY (1) MY8600389A (de)
NO (1) NO155038C (de)
NZ (1) NZ197744A (de)
PH (1) PH16308A (de)
PL (1) PL135416B1 (de)
PT (1) PT73391B (de)
RO (1) RO82678A (de)
SG (1) SG72085G (de)
ZW (1) ZW17181A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0095813A3 (de) * 1982-06-01 1985-05-08 THE PROCTER & GAMBLE COMPANY Durchdringende topische pharmazeutische Präparate, die 9-(2-Hydroxyäthoxymethyl)-guanin enthalten
US4557934A (en) 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
GB8602346D0 (en) * 1986-01-30 1986-03-05 Wellcome Found Antiviral combinations
GB8917959D0 (en) * 1989-08-05 1989-09-20 Beecham Group Plc Pharmaceutical formulation
US6469015B1 (en) 1990-01-26 2002-10-22 Novartis International Pharmaceutical Ltd Pharmaceutical formulation
GB9001886D0 (en) * 1990-01-26 1990-03-28 Beecham Group Plc Pharmaceutical formulation
DK0561465T3 (da) * 1992-03-20 1998-04-14 Unichema Chemie Bv Slipmiddelsammensætning
DK169121B1 (da) * 1992-09-09 1994-08-22 Gea Farmaceutisk Fabrik As Antiviralt virksom farmaceutisk olie-i-vand-emulsion indeholdende 9-[(2-hydroxyethoxy)methyl]guanin (acyclovir) eller et salt eller en ester deraf
DE4416674C2 (de) * 1994-05-11 1997-01-30 Rentschler Arzneimittel Topische Zubereitung enthaltend Aciclovir
DE19517147C2 (de) * 1995-05-10 1999-07-01 Hexal Pharmaforschung Gmbh Aciclovir-Zubereitung
WO1997034607A1 (en) * 1996-03-20 1997-09-25 Glaxo Group Limited Topical formulations of aciclovir
GB9611167D0 (en) * 1996-05-29 1996-07-31 Glaxo Group Ltd Medicaments
GB9718568D0 (en) 1997-09-03 1997-11-05 Chauvin Pharmaceuticals Limite Compositions
GB9718791D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Medicaments
ITMI981528A1 (it) * 1998-07-03 2000-01-03 Recordati Ind Chimica E Farma Formulazioni topiche di aciclovir
US7223387B2 (en) 1998-11-18 2007-05-29 Medivir Ab Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester
GB9828620D0 (en) * 1998-12-23 1999-02-17 Glaxo Group Ltd Medicaments
FR2837102B1 (fr) * 2002-03-18 2004-10-08 Palbian Snc Composition a l'etat de gel aqueux, procede de fabrication et utilisation pour la fabrication d'un medicament, notamment antiherpetique
US8697712B2 (en) * 2004-04-05 2014-04-15 Laboratorios Liomont, S.A. De C.V. Presentation of an antiviral pharmaceutical composition
EP2005824A1 (de) † 2007-06-21 2008-12-24 Bayer CropScience AG Wirkstoffsuspensionen in Glycerin
WO2017029298A1 (en) 2015-08-17 2017-02-23 Sanovel Ilac Sanayi Ve Ticaret A.S. A topical antiviral composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3892857A (en) * 1972-11-24 1975-07-01 Squibb & Sons Inc Steroid formulation
ZA738657B (en) * 1973-01-05 1974-10-30 Hoffmann La Roche Emulsions
GB1478009A (en) * 1973-04-02 1977-06-29 Glaxo Lab Ltd Pharmaceutical compositions
US4199574A (en) * 1974-09-02 1980-04-22 Burroughs Wellcome Co. Methods and compositions for treating viral infections and guanine acyclic nucleosides
GB1543907A (en) * 1975-02-19 1979-04-11 Dermal Labor Ltd Steroid compositions
US3934013A (en) * 1975-02-21 1976-01-20 Syntex (U.S.A.) Inc. Pharmaceutical composition
US4049802A (en) * 1975-03-19 1977-09-20 Research Corporation Zinc sulfadiazine and its use in the treatment of burns
GB1554720A (en) * 1975-07-10 1979-10-24 Nyegaard & Co As Pyridthione derivatives
US4141976A (en) * 1976-01-05 1979-02-27 The Regents Of The University Of Michigan Process for alleviating proliferative skin diseases
DE2847975A1 (de) * 1978-11-04 1980-05-14 Merck Patent Gmbh Verfahren zur bindung von freiem formaldehyd in pharmazeutischen und kosmetischen zubereitungen

Also Published As

Publication number Publication date
PH16308A (en) 1983-09-05
PL232259A1 (en) 1983-07-04
IL63351A0 (en) 1981-10-30
FI76255B (fi) 1988-06-30
ES504046A0 (es) 1983-04-01
HU185936B (en) 1985-04-28
CA1172169A (en) 1984-08-07
IE811617L (en) 1982-01-18
MY8600389A (en) 1986-12-31
DK321681A (da) 1982-01-19
DK149191C (da) 1986-09-08
NO812464L (no) 1982-01-19
AU547391B2 (en) 1985-10-17
AT381025B (de) 1986-08-11
EP0044543B1 (de) 1984-06-06
FI76255C (fi) 1990-03-14
AR225680A1 (es) 1982-04-15
RO82678A (ro) 1984-05-23
DD203464A5 (de) 1983-10-26
GR75104B (de) 1984-07-13
AU7307381A (en) 1982-01-21
DK149191B (da) 1986-03-10
DE3163982D1 (en) 1984-07-12
SG72085G (en) 1986-05-02
NO155038B (no) 1986-10-27
CY1309A (en) 1985-12-06
BG60450B2 (bg) 1995-04-28
GB2080106B (en) 1984-03-07
MC1408A1 (fr) 1982-07-16
NZ197744A (en) 1983-05-10
ES8305363A1 (es) 1983-04-01
FI812257L (fi) 1982-01-19
IT1171399B (it) 1987-06-10
CS229674B2 (en) 1984-06-18
EP0044543A1 (de) 1982-01-27
IL63351A (en) 1983-10-31
PT73391B (en) 1983-06-15
PT73391A (en) 1981-08-01
NO155038C (no) 1987-02-04
IE51120B1 (en) 1986-10-01
ZW17181A1 (en) 1983-02-23
IT8148925A0 (it) 1981-07-17
GB2080106A (en) 1982-02-03
HK95485A (en) 1985-12-06
PL135416B1 (en) 1985-10-31

Similar Documents

Publication Publication Date Title
LU77562A1 (de) Verfahren zur herstellung von neuen pharmazeutischen praeparaten
ATA318081A (de) Verfahren zur herstellung von topischen verfahren zur herstellung von topischen pharmazeutischen zubereitungen pharmazeutischen zubereitungen
AT371709B (de) Verfahren zur herstellung von pharmazeutischen praeparaten in dosiereinheitsform
AT360654B (de) Verfahren zur herstellung von pharmazeutischen zusammensetzungen
AT364451B (de) Verfahren zur herstellung von lokalanaesthetisch wirksamen kombinationspraeparaten
AT383271B (de) Verfahren zur herstellung von cerebralwirksamen arzneimitteln
AT371708B (de) Verfahren zur herstellung von pharmazeutischen einheitsdosierungsformen
AT366576B (de) Verfahren zur herstellung von pharmazeutischen praeparaten
AT367295B (de) Verfahren zur herstellung von pharmazeutischen zusammensetzungen
AT372856B (de) Verfahren zur herstellung von humanem relaxin
AT359197B (de) Verfahren zur herstellung von pharmazeutischen praeparaten
ATA221181A (de) Verfahren zur herstellung von einer pharmazeutischen zusammensetzung
ATA294581A (de) Verfahren zur herstellung von karamelpraeparaten in gepulverter form
AT372279B (de) Verfahren zur herstellung galenischer zubereitungen
AT363174B (de) Verfahren zur herstellung von pharmazeutischen zubereitungen
AT365452B (de) Verfahren zur herstellung pharmazeutischer praeparate
AT383272B (de) Verfahren zur herstellung von pharmazeutischen tabletten
AT378915B (de) Verfahren zur herstellung von antihypertensiven pharmazeutischen zubereitungen
ATA136279A (de) Verfahren zur herstellung von pharmazeutischen praeparaten
AT366574B (de) Verfahren zur herstellung von pharmazeutischen praeparaten zur oralen verabreichung
AT374828B (de) Verfahren zur herstellung von humaninterferon
AT371710B (de) Verfahren zur herstellung galenischer zubereitungen
AT383735B (de) Verfahren zur herstellung von wasserloeslichen pharmazeutischen zusammensetzungen
AT370759B (de) Verfahren zur herstellung von bitumenpraeparaten
AT370716B (de) Verfahren zur herstellung von naphthacendionderivaten

Legal Events

Date Code Title Description
ELA Expired due to lapse of time